Delivery Order SPE2DB20D3505-SPE2DB25FT4S6

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $17,249.08 firm fixed-price delivery order is for the supply of OXCARBAZEPINE ER 600 MG TABLET 100S, a generic medication. The contract has an ultimate completion date of November 8, 2024 and was awarded on November 7, 2024. The performance location is Conshohocken, PA. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,090.18 Firm Fixed Price Delivery Order is for the supply of 4,566,615,636 units of OXCARBAZEPINE 600 MG TABLET 500S, with a completion date of December 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $3,843.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OXCARBAZEPINE ER 150 MG TABLET 100S, a prescription medication, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 1, 2024. It is not designated as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4566734673 OXCARBAZEPINE ER 600 MG TABLET 100S. The contract has a ceiling value of $5,945.20 and an ultimate completion date of December 17, 2024. This award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is for the delivery of Oxcarbazepine 300 mg tablets (100 counts) to the Defense Logistics Agency (DLA). The $3,827.32 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of March 15, 2022 and was awarded on March 14, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,436.26, is a delivery order for 4567008506 - OXCARBAZEPINE 300 MG/5 ML SUSP 250ML. It is a firm fixed-price contract with a completion date of January 23, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,293.61 Firm Fixed Price Delivery Order covers the supply of 4,561,172,515 units of Oxcarbazepine 300 mg Tablets in 100-count bottles, with a completion date of June 8, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a substantial Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,608.01 firm-fixed-price delivery order is for the supply of 4,565,933,418 units of Oxcarbazepine 600 mg tablets. The award has an ultimate completion date of September 26, 2024 and is not a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued up to $999,999,999 through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,259.73, is for the delivery of oxcarbazepine 300 mg/5 ml suspension, a generic anticonvulsant medication, with a completion date of February 25, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The $4,104.42 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FT4S6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,541.50 Firm Fixed Price Delivery Order is for the supply of 4566514910 OXCARBAZEPINE ER 300 MG TABLET 100S, with a period of performance through November 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with any set-aside requirements, indicating open competition. The contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through the DLA's medical commodity procurement.

Generated 2/27/25, 11:15 AM